A multispecies study to assess the toxic and genotoxic effect of pharmaceuticals: Furosemide and its photoproduct

Chemosphere

Volumn 63, Issue 5, 2006, Pages 785-793

  Isidori, Marina ^a,b   Nardelli, Angela ^a,b   Parrella, Alfredo ^a,b   Pascarella, Luigia ^a,b   Previtera, Lucio ^a,b  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Furosemide; Genotoxicity; Mutagenesis; Photoproduct; Toxicity testing

Indexed keywords

CONCENTRATION (PROCESS); ENVIRONMENTAL IMPACT; GROUNDWATER; METABOLITES; MUTAGENESIS; POTABLE WATER; TOXIC MATERIALS; TOXICITY; WATER POLLUTION;

FUROSEMIDE; GENOTOXICITY; PHOTOPRODUCTS; TOXICITY TESTING;

DRUG PRODUCTS;

DIURETIC AGENT; DRINKING WATER; FUROSEMIDE; GROUND WATER;

CONCENTRATION (PROCESS); DRUG PRODUCTS; ENVIRONMENTAL IMPACT; GROUNDWATER; METABOLITES; MUTAGENESIS; POTABLE WATER; TOXIC MATERIALS; TOXICITY; WATER POLLUTION;

AQUATIC ENVIRONMENT; BIOASSAY; CRUSTACEAN; DRINKING WATER; DRUG; GROUNDWATER; INHIBITION; METABOLITE; MUTAGENICITY; TOXICITY;

ALGA; AMES TEST; AQUATIC ENVIRONMENT; ARTICLE; BACTERIUM; BIOASSAY; CALCULATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CRUSTACEA; ECOTOXICITY; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL IMPACT; GENOTOXICITY; MUTAGENICITY; NONHUMAN; PREDICTION; RISK ASSESSMENT; SOS CHROMOTEST; WASTE WATER;

ALGAE; ANIMALIA; BACTERIA (MICROORGANISMS); CRUSTACEA; ROTIFERA;

EID: 33646017364     PISSN: 00456535     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.chemosphere.2005.07.078     Document Type: Article

References (60)

1. Agygralides G.G., Dallas P.P., and Rekkas D.M. Development and in vitro evaluation of furosemide transdermal formulations using experimental design techniques. Int. J. Pharm. 281 (2004) 35-43
2. Andreozzi R., Marotta R., and Paxéus N. Pharmaceuticals in STP effluents and their solar photodegradation in aquatic environment. Chemosphere 50 (2003) 1319-1330
3. APHA (American Public Health Association), 1998. Standard Methods for the examination of water and wastewater, 20th ed., 8030 B Salmonella Microsomal Mutagenicity Test, Washington, DC.
4. ASTM (American Society for Testing and Materials), 1991. Standard guide for acute toxicity with the rotifer Brachionus. E 1440-91. Philadelphia, PA, USA.
5. Benigni R., Andreoli C., and Giuliani A. Relationships among in vitro mutagenicity assays: quantitative vs. qualitative tests results. Environ. Mol. Mutagen. 26 (1995) 155-162
6. Boree A.N., Arnold W.A., and McNeill K. Photodegradation of pharmaceuticals in the aquatic environment: a review. Aquat. Sci. 65 (2003) 320-341
7. Boyd G.R., Reemtsma H., Grimm D.A., and Mitra S. Pharmaceuticals and personal care products (PPCPs) in surface and treated waters of Louisiana, USA and Ontario, Canada. Sci. Total Environ. 311 (2003) 135-149
8. Brigante M., DellaGreca M., Isidori M., Nardelli A., Previtera L., Rubino M., and Temussi F. Phototransformation and ecotoxicity of Naproxen Na. Environ. Chem. Lett. 1 (2004) 237-241
9. Bulich A.A. Use of luminescent bacteria for determining toxicity in aquatic environments. In: Marking L.L., and Kimerle R.A. (Eds). Aquatic Toxicology: Second Conference. STP 667 (1979), ASTM (American Society for Testing and Materials), Philadelphia, PA, USA 98-106
10. Bundgaard H., Nørgaard T., and Nielsen N.M. Photodegradation and hydrolysis of furosemide and furosemide esters in aqueous solutions. Int. J. Pharm. 42 (1988) 217-224
11. Calamari D., Zuccato E., Castiglioni S., Bagnati R., and Fanelli R. Strategic survey of therapeutic drugs in the rivers Po and Lambro in Northern Italy. Environ. Sci. Technol. 37 (2003) 1241-1248
12. Castiglioni S., Fanelli R., Calamari D., Bagnati R., and Zuccato E. Methodological approaches for studying pharmaceuticals in the environment by comparing predicted and measured concentrations in River Po, Italy. Regul. Toxicol. Pharmacol. 39 (2004) 25-32
13. Christen F.M. Pharmaceuticals in the environment: a human risk. Regul. Toxicol. Pharmacol. 28 (1998) 212-221
14. Daughton C.G., and Ternes T.A. Pharmaceuticals and personal care products in the environment: agents of subtle change?. Environ. Health Perspect. 107 Suppl. 6 (1999) 907-938
15. Dayan J., Deguingand S., Truzman C., and Chevron M. Application of the SOS Chromotest to 10 pharmaceutical agents. Mutat. Res. 187 (1987) 55-66
16. DellaGreca M., Fiorentino A., Iesce M.R., Isidori M., Nardelli A., Previtera L., and Temussi F. Identification of phototransformation products of prednisone by sun-light. Toxicity of the drug and its derivatives on aquatic organisms. Environ. Toxicol. Chem. 22 (2003) 534-539
17. DellaGreca M., Fiorentino A., Isidori M., Lavorgna M., Previtera L., Rubino M., and Temussi F. Toxicity of prednisolone, dexamethasone and their photochemical derivatives on aquatic organisms. Chemosphere 54 (2004) 629-637
18. DellaGreca M., Iesce M.R., Previtera L., Rubino M., and Temussi F. A new photoproduct of the drug furosemide in aqueous media. Environ. Chem. Lett. 2 (2004) 155-158
19. Derksen J.G.M., Rijs G.B.J., and Jongbloed R.H. Diffuse pollution of surface water by pharmaceutical products. Water. Sci. Technol. 49 (2004) 213-221
20. Doll T.E., and Frimmel F.H. Fate of pharmaceuticals-photodegradation by simulated solar UV-light. Chemosphere 52 (2003) 1757-1769
21. EMEA, 2003. Note for guidance on environmental risk assessment of medicinal products for human use. CPMP/SWP/4447/00 draft. European Agency for the Evaluation of Medicinal Products.
22. Ferrari B., Paxeus N., Lo Giudice R., Pollio A., and Garric J. Ecotoxicological impact of pharmaceuticals found in treated wastewaters: study of carbamazepine, clofibric acid, and diclofenac. Ecotoxicol. Environ. Safety 55 (2003) 359-370
23. Gold L.S., Slone T.H., Stern B.R., and Bernstein L. Comparison of target organs of carcinogenicity for mutagenic and non-mutagenic chemicals. Mutat. Res. 286 (1993) 75-100
24. Gotardo M.A., Gigante A.C., Pezza L., and Pezza H.R. Determination of furosemide in pharmaceutical formulations by diffuse reflectance spectroscopy. Talanta 64 (2004) 361-365
25. Halling-Sørensen B., Nors Nielsen S., Lanzky P.F., Ingerslev F., Holten Lützhoft H.C., and Jørgensen S.E. Occurrence, fate and effects of pharmaceutical substances in the environment-a review. Chemosphere 36 (1998) 357-393
26. Halling-Sørensen B., Sengelov G., and Tjornelund J. Toxicity of tetracycline degradation products to environmentally relevant bacteria, including, selected tetracycline-resistant bacteria. Arch. Environ. Contam. Toxicol. 42 (2002) 263-271
27. Heberer T. Occurrence, fate, and removal of pharmaceutical residues in the aquatic environment: a review of recent research data. Toxicol. Lett. 131 (2002) 5-17
28. Hirsch R., Ternes T., Haberer K., and Kratz K.L. Occurrence of antibiotics in the aquatic environment. Sci. Total Environ. 225 (1999) 109-118
29. Hofnung M., and Quillardet P. Recent developments in bacterial short-term tests for detection of genotoxic agents. Mutagenesis 1 (1986) 319-330
30. Isidori M., Lavorgna M., Nardelli A., Pascarella L., and Parrella A. Toxic and genotoxic evaluation of six antibiotics on non-target organisms. Sci. Total Environ. 346 (2005) 87-98
31. Isidori, M., Lavorgna, M., Nardelli, A., Parrella, A., Previtera, L., Rubino, M., 2005b. Ecotoxicity of naproxen and its phototransformation products. Sci. Total Environ., in press.
32. ISO, 1989. Water quality-Algal growth inhibition test. ISO/DIS 8692. International Organization for Standardization, Geneva, Switzerland.
33. ISO, 1996. Water Quality-Determination of the inhibition of the mobility of Daphnia magna Straus (Cladocera, Crustacea)-Acute toxicity test. ISO/6341. International Organization for Standardization, Geneva, Switzerland.
34. ISO, 2001a. Water quality-Determination of chronic toxicity to Ceriodaphnia dubia in 7 days-Population growth inhibition test. ISO/CD 20665. International Organization for Standardization, Geneva, Switzerland.
35. ISO, 2001b. Water quality-Determination of chronic toxicity to Brachionus calyciflorus in 48 h-Population growth inhibition test. ISO/CD 20666. International Organization for Standardization, Geneva, Switzerland.
36. Jolibois B., Guerbet M., and Vassal S. Detection of hospital wastewater genotoxicity with the SOS Chromotest and Ames fluctuation test. Chemosphere 51 (2003) 539-543
37. Jones O.A.H., Voulvoulis N., and Lester J.N. Aquatic environmental assessment of the top 25 English prescription pharmaceuticals. Water Res. 36 (2002) 5013-5022
38. Jos A., Repetto G., Rios J.C., Hazen M.J., Molero M.L., del Peso A., Salguero M., Fernàndez-Freire P., Pèrez-Martìn J.M., and Cameàn A. Ecotoxicological evaluation of carbamazepine using six different model systems with eighteen endpoints. Toxicol. in Vitro 17 (2003) 525-532
39. Kolpin D.W., Furlong E.T., Meyer M.T., Thurman E.M., Zaugg S.D., Barber L.B., and Buxton H.T. Pharmaceuticals, hormones and other organic wastewater contaminants in US streams, 1999-2000: a national reconnaissance. Environ. Sci. Technol. 36 (2002) 1202-1211
40. Kümmerer K., Al-Ahmad A., and Mersch-Sundermann V. Biodegradability of some antibiotics, elimination of the genotoxicity and affection of wastewater bacteria in a simple test. Chemosphere 40 (2000) 701-710
41. Maron D.M., and Ames B.N. Revised methods for the Salmonella mutagenicity test. Mutat. Res. 113 (1983) 173-215
42. Microtox Manual, 1995. Acute toxicity Basic Test procedures. Microbics Corporation, Carlsbad, CA, USA.
43. Mortelmans K., and Zeiger E. The ames salmonella/microsome mutagenicity assay. Mutat. Res. 455 (2000) 29-60
44. Pascoe D., Karntanut W., and Muller C.T. Do pharmaceuticals affect freshwater invertebrates. A study with the cnidarian Hydra vulgaris. Chemosphere 51 (2003) 521-528
45. Peltier, W.H., Weber, C.I., 1985. Methods for measuring the acute toxicity of effluents to freshwater and marine organisms. EPA-600/4-85-013. Environmental Protection Agency, Washington, DC, USA.
46. Quillardet P., and Hofnung M. The SOS Chromotest, a colorimetric bacterial assay for genotoxins: procedures. Mutat. Res. 147 (1985) 65-78
47. Quillardet P., and Hofnung M. The SOS Chromotest: a review. Mutat. Res. 297 (1993) 235-279
48. Rosenkranz H.S., and Karol M.H. Chemical carcinogenicity: can it be predicted from knowledge of mutagenicity and allergic contact dermatitis?. Mutat. Res. 431 (1999) 81-91
49. Stuer-Lauridsen F., Birkved M., Hansen L.P., Holten Lutzhoft H.C., and Halling-Sorensen B. Environmental risk assessment of human pharmaceuticals in Denmark after normal therapeutic use. Chemosphere 40 (2000) 783-793
50. Stumpf M., Ternes T.A., Wilken R.D., Roodrigues S.V., and Baumannn W. Polar drug residues in sewage and natural waters in the state of Rio de Janeiro, Brazil. Sci. Total Environ. 225 (1999) 135-141
51. Ternes T.A. Occurrence of drugs in German sewage treatments plants and rivers. Water Res. 32 (1998) 3245-3260
52. Thamnotoxkit F™, 1995. Crustacean toxicity screening test for freshwater. Standard Operational Procedure. Creasel, Deinze, Belgium.
53. Tixier C., Singer H.P., Oellers S., and Müller S.R. Occurence and fate of carbamazepine, ibuprofen, ketoprofen and naproxen in surface waters. Environ. Sci. Technol. 37 6 (2003) 1061-1068
54. Toxicity Data Analysis and Database Software (Toxcalc™, vers. 5.0), 1996. Tidepool Scientific Software and Michael A Ives, Mckinleyville, CA, USA.
55. USEPA, 1993. Methods for measuring the acute toxicity of effluents and receiving waters to freshwater and marine organisms, 4th ed. EPA-600-4-90-027F. US Environmental Protection Agency, Washington, DC.
56. Waters M.D., Stack H.F., Jackson M.A., and Bridges B.A. Hazard identification: efficiency of short-term tests in identifying germ cell mutagens and putative nongenotoxic carcinogens. Environ. Health Persp. Suppl. 101 Suppl. 3 (1998) 61-72
57. Winkler M., Lawrence J.R., and Neu T.R. Selective degradation of ibuprofen and clofibric acid in two modern river biofilm system. Water Res. 35 (2001) 3197-3205
58. Zanocco A., Gunther G., Lemp M.E., de La Fuente J.R., and Pizarro N.U. Kinetics and mechanism of the photosensitized oxidation of furosemide. Photochem. Photobiol. 68 (1998) 487-493
59. Zeiger E., Anderson B., Haworth S., Lawlor T., and Mortelmans K. Salmonella mutagenicity tests: IV. Results from the testing of 300 chemicals. Environ. Mutagen. 9 (1988) 1-158
60. Zuccato E., Calamari D., Natangelo M., and Fanelli R. Presence of therapeutic drugs in the environment. Lancet 335 (2000) 1789-1790